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Background: An increasing number of studies on stem cells suggests that the therapeutic effect they
exert is primarily mediated by a paracrine regulation through extracellular vesicles (EVs) giving solid
grounds for stem cell EVs to be exploited as agents for treating diseases or for restoring damaged tissues
and organs.
Due to their capacity to differentiate in all embryonic germ layers, amniotic ﬂuid stem cells (AFCs),
represent a highly promising cell type for tissue regeneration, which however is still poorly studied and
in turn underutilized. In view of this, we conducted a ﬁrst investigation on the expression of human
hTERT gene  known to be among the key triggers of organ regeneration  in AFCs and in the EVs they
secrete.
Methods: Isolated AFCs were evaluated by RT-qPCR for hTERT expression. The clones expressing the
highest levels of transcript, were analyzed by Immunoﬂuorescence imaging and Nuclear/cytoplasmic
fractionation in order to evaluate hTERT subcellular localization. We then separated EVs from FBS
depleted culture medium by serial (ultra) centrifugations steps and characterized them using Western
blotting, Atomic force Microscopy and Nanoplasmonic assay.
Results: We ﬁrst demonstrated that primary cultures of AFCs express the gene hTERT at different levels.
Then we evidenced that in AFCs with the higher transcript levels, the hTERT protein is present in the
nuclear and cytoplasmic compartment. Finally, we found that cytosolic hTERT is embodied in the EVs
that AFCs secrete in the extracellular milieu.
Conclusions: Our study demonstrates for the ﬁrst time the expression of the full protein hTERT by AFCs
and its release outside the cell mediated by EVs, indicating a new extra telomeric role for this protein.
This ﬁnding represents an initial but crucial evidence for considering AFCs derived EVs as new potential
sources for tissue regeneration.
© 2016 Elsevier Inc. All rights reserved.1. Introduction
The rapid advances in the ﬁeld of regenerative medicine have
identiﬁed novel sources of stem cells with potential for therapy.uid cells; EVs, Extracellular
(A. Radeghieri), giovanna.
ental of this work.
ieri, et al., Cultured human a
esicles, Biochemical and BiopRecently, the amniotic ﬂuid (AF) has been acknowledged as an
important and alternative, yet underutilized source of cells [1]. AF
cells (AFCs) represent a heterogeneous population composed of
three groups of adherent cells, categorized based on their
morphological, proliferative and biochemical characteristics:
epithelioid (E-type), amniotic ﬂuid (AF-type) and ﬁbroblastic (F-
type) cells [2]. In addition to fully differentiated cells, precursors
and multipotent stem like cells have been described within AF [3].
Those cells show high plasticity and the capacity to differentiate
into the three types of germ layer cells, making them ideal for ap-
plications in regenerativemedicine [4], eventually banked and used
for treatments.mniocytes express hTERT, which is distributed between nucleus and
hysical Research Communications (2016), http://dx.doi.org/10.1016/
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proaches requires in vitro culture expansion to achieve a sufﬁcient
number of cells and strict characterization of the cultures, two
factors that may severely hamper their clinical use [5].
In addition, very recent data indicate that the structural
contribution of stem cells (SCs) to regenerated tissues seems to be
limited, and that rather the stimulation of local healing processes
plays an important role in regeneration [6]. This observation
prompted research to focus on the paracrine hypothesis, investi-
gating the stimulating factors released by SCs, including growth
factors and cytokines, often delivered by extracellular vesicles (EVs)
[7,8]. Indeed, EVs derived frommesenchymal SCs have the ability to
induce tissue regeneration by delivering growth factors, proteins,
miRNA, mRNA, non coding RNA, and lipids [9]. Several reports have
demonstrated the feasibility to regenerate tissues and neo-
vascularization in models of myocardial infarction, skeletal muscle
and kidney injury using exosomes from SCs and endothelial pro-
genitor cells [10e12]. Thus it is feasible that, in the future, SC
derived EVs could be used instead of SC to treat various diseases
[13].
The ability of a cell to proliferate is an essential feature in the
regeneration process and is tightly linked to its ability to maintain
healthy telomeres and avoid DNA damage during DNA replication.
Telomerase is a ribonucleoprotein enzyme that maintains telo-
mere length by adding DNA repeats to chromosome ends [14].
Because of its ability to counteract telomere erosion, telomerase is
associated with the potential proliferation of cells and tissues [15]
and has been implicated in mouse liver regeneration [16] and
zebraﬁsh heart regeneration [17].
The hTERT protein is the catalytic subunit of telomerase and
plays a fundamental role during foetal growth. Its ectopic expres-
sion in normal human cells confers telomerase activity and stabi-
lizes telomere lengths. hTERT expression is stringently regulated in
most adult somatic tissues, which commonly, express no or very
low levels of hTERT mRNA [18] with several exceptions [19].
In the current study, we aimed to characterize the expression of
hTERT in AFCs, based on the capacity of these cells to differentiate in
SCs, and the possibility that AFCs secrete the protein via EVs.
Currently, no data are available on hTERT expression and localiza-
tion in these cells. Furthermore, no research yet studied if telo-
merase positive SCs could inﬂuence telomerase negative somatic
wounded cells via EV crosstalk. In a related way, a very recent paper
showed that hTERT mRNA contained in exosomes derived from
tumor cells is able to transform non malignant ﬁbroblasts into
telomerase positive cells [20], increasing proliferation, life span and
protecting them from DNA damage.
Our results describe for the ﬁrst time hTERT expression in AFCs
and that the whole protein is included in EVs derived from AFCs.
This data represents interesting evidence towards understanding
the promising therapeutic potential of these cells in regenerative
medicine, suggesting a possible mechanism by which those cells
could exert a positive effect towards neighboring wounded tissues,
which will be explored in the future.
2. Materials and methods
2.1. Cells cultures and hTERT gene asset
The study on amniotic ﬂuid was performed on 25 samples (12
were 46, XY and 13 were 46, XX), established following amnio-
centesis. A small aliquot of cells was obtained after the analysis and
the results of prenatal diagnosis. Written informed consents to use
the cells, only for research purposes, were obtained from the pa-
tients. All samples were rendered anonymous and stored, at pas-
sage 1, with the concentration of 1*106/ml in cryogenic system ofPlease cite this article in press as: A. Radeghieri, et al., Cultured human a
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sue culture Petri (Jet Bioﬁl) at 37 C, 5% CO2, with DMEM (Carlo
Erba) supplemented with 20% FBS 1% glutamine, 1% antibiotics
(Gibco).
Copy number variation (CNV) of hTERTwas used to evaluate the
number of hTERT gene copies to avoid the presence of cryptic
rearrangements. We used the following primers: TaqMan Copy
Number Reference Assay RNAse P and TaqMan Copy Number Assay
hs00233340 (exon 1 TERT) e hs01237576 (exon 16 TERT) (Applied
Biosystem).
Data processing was evaluated by software Copy Caller 1.0
(Applied Biosystem).
2.2. Gene expression
The total RNA from amniocytes samples was isolated using
TRIzol reagent (Invitrogen), according to the manufacturer's in-
structions and was transcribed into cDNA using random primers,
ribonuclease inhibitor andM-MLV reverse trascriptase (Invitrogen).
The expression of hTERT mRNA in the samples was evaluated
using TaqMan Gene Expression Assay (hs00972656 for hTERT)
(Applied Biosystem). GAPDH was used as an internal standard.
The expression of hTERT mRNA [17] was based on the DDCt
method.
2.3. Immunoﬂuorescence (IF) imaging
AFCs were cultured on 11 mm glass coverslips until 60e80%
conﬂuence. IF was performed following primary antibody data-
sheet instructions (rabbit anti-hTERT, Rockland Immunochemicals
Inc.). Confocal microscopywas performed on a ZEISS LSM 510META
confocal laser scanning microscope using the 63 or the 100
Plan-NEOFLUAR oil immersion objective. Single confocal sections
are shown for each condition. Images were processed with the use
of Image J [21].
2.4. Nuclear/cytoplasmic fractionation
Fractionation of AFCs was performed as described [22]. Whole
cell homogenate, cytosolic and nuclear fractions were boiled and
loaded on a SDS-PAGE as described below.
2.5. Western-blot analysis
SDS sample buffer was added to isolated EVs or cellular extracts
and samples were boiled 5 min at 95 C. Samples were electro-
phoresed in SDS-PAGE 10% and analyzed by Western-blot (WB)
with rabbit anti-hTERT (Rockland Immunochemicals Inc.) [23],
mouse anti-Hsp 70 (Enzo Life Science), mouse anti-CD63 (Merck),
mouse anti-Annexin-V (Santa Cruz) and/or mouse anti-Lamin A/C
(Thermoﬁsher) antibodies.
2.6. EV separation and characterization
Cell culture media from 5*107 cultured cells, grown in the
presence of 10% vesicle depleted FBS, was processed with serial
centrifugation steps as previously described [24]. Pellets were re-
suspended in 50 mL PBS 1 supplemented with 1:1000 Protease
Inhibitor Cocktail (Sigma).
EV preparations were checked for purity by adapting the
colorimetric nanoplasmonic assay we previously developed [25].
For AFM imaging, EV preparations were diluted 1:10 with
deionized water. Five to 10 mL of samples were then spotted onto
freshly cleaved mica sheets (Grade V-1, thickness 0.15 mm, size
10  10 mm). All mica substrates were dried at RT and analyzedmniocytes express hTERT, which is distributed between nucleus and
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Tap190AI-G tips (Budget Sensors). Images were snapped in tapping
mode; the scan size ranged from 0.5 mm to 15 mm; the scan speed
ranged from 0.6 to 1.5 s x line.
EV size distribution was obtained by image analysis of three
representative AFM images of scan size 5  5 mm performed by the
WSxM 5.0 software (http://www.wsxmsolutions.com).
EV biochemical characterizationwas performed byWestern blot
as described above.3. Results and discussion
3.1. hTERT gene is present in a diploid asset in AFCs but the
expression is different among samples
In order to evaluate hTERT gene expression in AFCs we used
frozen samples stored in our cell bank. After thawing, all samples of
AFCs demonstrated the capacity to grow and triplicated the growth
within 14 days, in according with literature [5]. All experiments
were performed at passage 3 on the heterogeneous cellular popu-
lation obtained by expansion of the samples after thawing. We
deliberately planned to investigate this population of AFCs because
cells are generally frozen and banked in this heterogeneous con-
dition. If necessary, they might be differentiated towards mesen-
chymal stem cells or the three types of germ layer cells.
We evaluated the diploid asset of hTERT gene by genomic DNA
CNV analysis, conﬁrming that in all samples the hTERT is present in
two copies (data not shown). Gene expression studies showed
heterogeneous expression levels for hTERT gene among samples
(Fig. 1). The gene is expressed in 18/25 samples analyzed (72%) with
a RQ value (RQ ¼ 2eDDCt) comprised between 1 and 11.8. The
detection and the variability of expression values suggest the hy-
pothesis that they are probably correlated to the presence of
different cell types in the AF samples as previously described [4].3.2. hTERT protein is expressed in amniocytes and is partitioned
between nuclei and cytoplasm
hTERT protein expression is regulated by a complex system,
predominantly involving transcriptional and translational control.
It has been shown that the subcellular location of hTERT is dynamic
and dependent on the cell cycle, DNA damage or cellular trans-
formation [26]. Notably, a number of studies have shown that
hTERT, which is regarded as a nuclear protein, has been identiﬁedFig. 1. hTERT Gene Expression. (RQ ¼ 2eDDCt). The gene is expressed in 18 of samples
analyzed with a RQ value (RQ ¼ 2eDDCt) comprised between 1 and 11.8.
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different tumor cell lines and peripheral blood cells. In addition, it is
subjected to CRM-1 dependent nucleocytoplasmic trafﬁcking [27].
hTERT subcellular localization remains however a controversial
issue [28]. Since hTERT protein expression has never been shown in
amniocytes before, we wanted to visualize its presence and sub-
cellular localization in selected AFCs, which showed a good gene
expression pattern (RQ value above 4, 8 samples). We separated the
nuclear fraction from the cytosolic pool as indicated in Materials
and methods. As shown in Fig. 2A, hTERT protein is mainly
concentrated in the nucleus of the cells, but the presence of the
protein is also detectable in the cytosolic fraction. Immunoﬂuo-
rescence (IF) staining performed on the same AFCs grown on glass
coverslips also corroborates this result. Cells were ﬁxed, per-
meabilized and analyzed using the rabbit anti-hTERT antibody.
Fig. 2B shows a speciﬁc staining of the protein in the nucleus,
especially in nucleoli, and in the cytoplasm, in reticulated like
structures. Furthermore, it is to notice that the staining is different
among the cell population. Actually, some cells have a low nucle-
olar staining but a strong non dispersed cytosolic signal, possibly
related to ﬁlaments of actin or tubulin. This distribution appears in
accordance with literature data, showing that knockdown of hTERT
alters the biophysical properties of cells leading to reorganization
of the cytoskeleton [29].
Thus we can conclude that in AFCs the protein hTERT is
expressed and its subcellular localization is not only conﬁned to
nuclei but can be dispersed throughout the cytosol, meaning that in
those cells hTERT might play different functions [30] and might be
directed to different routes. hTERT distribution shows a variability
among AFCs considered, which might be due to single cell condi-
tions, cell cycle, or cell type considered.
3.3. hTERT protein is embodied in extracellular vesicles secreted by
AFCs
EVs were isolated from cell culture medium of AFCs obtained
from different amniotic ﬂuids selected for normal diploid karyo-
type and hTERT RQ value above 4. AFCs were cultured in DMEM
medium supplemented with vesicles depleted FBS. EVs were pu-
riﬁed by means of serial centrifugations to eliminate cellular debris
and big protein aggregates from 40 mL of cell medium obtained
from 90% conﬂuent T75 ﬂasks.
We ﬁrst assessed the purity of EV samples by applying a color-
imetric nanoplasmonic assay, which exploits the colloidal and op-
tical properties of gold nanoparticle (AuNPs) solutions [25]. Brieﬂy,
bare AuNPs adsorb and cluster at the EV membrane in pure prep-
arations. Instead, if the preparations contain exogenous contami-
nants, AuNPs are preferentially coated by those contaminants,
which prevent AuNPs from clustering. Aggregation drives a red
shift of the localized surface plasmon resonance (LSPR) absorption
peak of the AuNPs (Fig. S1), leading the solution to a red to blue
color change proportional to the purity grade of the added EV
preparation.
AuNPs clustering can be quantiﬁed by the Aggregation Index
(AI), which directly relates the AuNP aggregation with preparation
purity grade. AI can be determined from the sample UV/Vis spectra
and is here conveniently deﬁned as the ratio between the 519 nm
and 650 nm LSPR absorbance (AI ¼ A519/A650). AI decreases along
with the change of the solution color from red to blue, and is
inversely proportional to the preparation purity. The determined AI
for our samples is around 2.58 (Fig. 3A), close to the reference value
of the pure AuNP solution, corresponding to a high purity level.
The morphological properties of the vesicles and their size
distributionwere determined bymeans of atomic force microscopy
(AFM). EV preparation was adsorbed on a freshly cleaved micamniocytes express hTERT, which is distributed between nucleus and
hysical Research Communications (2016), http://dx.doi.org/10.1016/
Fig. 2. Subcellular localization of hTERT protein in AFCs. (A) Amniocytes in culture were subjected to subcellular fractionation as described in Materials and methods. Western-
blot analysis of subcellular fractions is shown in ﬁgure: H (whole cell lysate), C (cytosolic proteins) and N (nuclear fraction). (B) hTERT subcellular localization by immunoﬂuo-
rescence analysis. Amnyocites were ﬁxed with PFA 4%, permeabilized with NP-40 0.2% and stained with rabbit anti-hTERT antibody. Scale bars, 5 mm.
Fig. 3. Biochemical and biophysical characterization of AFC EVs. (A) Aggregation Index (AI) of amniocytes EV preparation. AI was calculated as the ratio between the 519 nm and
650 nm LSPR absorbance. AI decreases along with the change of the solution color from red to blue, and is inversely proportional to the preparation purity. (B) AFM topography
image of AFC EVs. (C) Size distribution of AFC EVs. A total of 623 objects with a diameter between 30 and 1000 nmwere analyzed. Off-scale objects were not included in the analysis
(10% of the total). Median ~133 nm. (D) Western blot showing the presence of EV markers CD63, HSP70, Annexin V and hTERT. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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displayed in Fig. 3B shows the imaged portion of the sample is
composed by EVs with a size ranging from tens to few hundreds of
nm. The black background indicates the absence of any relevant
nanoscale feature other than the EVs (with reference to the color
code bar), conﬁrming the absence of residual contaminants from
the separation procedure and the purity of the sample [31]. Image
analysis allowed to quantify and plot the size distribution of the
EVs, which is reported in bar chart form in Fig. 3C. Remarkably, the
distribution is asymmetrical, ranging from 30 nm to 240 nmPlease cite this article in press as: A. Radeghieri, et al., Cultured human a
cytoplasm and is secreted in extracellular vesicles, Biochemical and Biop
j.bbrc.2016.12.077peaking at the size of 60e70 nm. This observation indicates that
AFCs EV population is prevalently composed by EVs with a size
below 100 nm, which is the typical size of exosomes.
We then performed a biochemical characterization of the sam-
ples by Western Blot analysis using the conventional EV markers
HSP70, CD63 and Annexin-V, which we all found expressed in our
vesicles. Through Western Blotting, we also discovered for the ﬁrst
time the presence of hTERT in those samples, showing a clear band
at around 130 kDa (Fig. 3D).
As it has been documented before [32], exosomes are small EVsmniocytes express hTERT, which is distributed between nucleus and
hysical Research Communications (2016), http://dx.doi.org/10.1016/
Fig. 4. Schematics of envisioned hTERT role in regenerative medicine. hTERT is localized in different compartments of the cells. A subpopulation of the protein is enclosed in EVs
and delivered in the extracellular milieu. Here, EVs could be easily taken up by neighboring wounded cells and help to restore telomerase activity, which would help cells to
proliferate and heal the tissue.
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compartment, the multivesicular body (MVB). As a result of an
engulfment of cytosolic material they contain several cytosolic
proteins. By our biochemical and biophysical analyses we can
speculate that the main population of vesicles secreted by AFCs is
composed of exosomes. Since we found that hTERT is also localized
in the cytoplasmic compartment, we suppose that “gulps” of
cytosol containing hTERT are enclosed in intraluminal vesicles in
MVB, which are then released.
It has recently been demonstrated that hTERTmRNA is delivered
via exosomes to ﬁbroblasts and modulates telomerase activity on
these cells [20]. To this ﬁnding we add that the whole ready to go
protein is enclosed in AFCs derived exosomes, suggesting that the
effect previously described might be induced by the protein
transferred itself and not only by mRNA transfer. This could mean a
quicker activation of the processes described.
It could be also possible that a portion of cytosolic hTERT might
be freely released in the extracellular milieu: we deliberately did
not investigate this hypothesis since it seems unlikely that the
protein could be endocytosed by cells as a functional molecule.
Furthermore, the transfer of functional biological molecules by EVs
is being more and more unveiled together with the effect exerted
by EVs towards target cells [33], as we envision for hTERT in Fig. 4.
This ﬁnding, if veriﬁed on AFCs towards somatic wounded cells
(experimental work has been started), could open the route to
studies for the employment of AFCs in healing tissues and regen-
erative medicine developing new avenues for future research.Acknowledgements
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